peptides leaky gut FAQ

Temporary symptom exacerbation during NF-κB inhibition can occur as bacterial endotoxin clearance increases. When KPV reduces intestinal inflammation, previously sequestered LPS (lipopolysaccharide) in inflamed tissue gets mobilised into lymphatic circulation before liver clearance. Creating transient endotoxemia symptoms (fatigue, brain fog, low-grade fever). This typically resolves within 5–7 days as hepatic detoxification catches up. If symptoms persist beyond two weeks or worsen progressively, discontinue and evaluate for underlying infection or SIBO that KPV's anti-inflammatory effects may be masking.

Switch focus to tight junction-specific interventions. L-glutamine provides fuel for enterocyte metabolism but doesn't upregulate occludin or ZO-1 gene expression. The structural proteins that seal paracellular spaces. If you've been supplementing L-glutamine at 5–10g daily for 12+ weeks without measurable symptom change (bloating, food sensitivity reduction, energy improvement), the issue likely isn't substrate availability but tight junction protein downregulation driven by chronic inflammation or NSAID damage. BPC-157 at 250–500mcg daily directly addresses this by stimulating VEGF production, which increases blood flow to damaged mucosa and accelerates epithelial cell turnover.